These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 10396285)
1. Estrogen and progesterone receptor contents in ThinPrep-processed fine-needle aspirates of breast. Leung SW; Bédard YC Am J Clin Pathol; 1999 Jul; 112(1):50-6. PubMed ID: 10396285 [TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study. Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033 [TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients. Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582 [TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Radhika K; Prayaga AK Indian J Cancer; 2010; 47(2):148-50. PubMed ID: 20448377 [TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas. Skoog L; Humla S; Isaksson S; Tani E Diagn Cytopathol; 1990; 6(2):95-8. PubMed ID: 2186900 [TBL] [Abstract][Full Text] [Related]
6. Assessing estrogen and progesterone receptor status in fine needle aspirates from breast carcinomas. Results on six years of material and correlation with biochemical assay. Sauer T; Beraki E; Jebsen PW; Amlie E; Harbitz T; Kåresen R; Naess O Anal Quant Cytol Histol; 1998 Apr; 20(2):122-6. PubMed ID: 9569969 [TBL] [Abstract][Full Text] [Related]
7. Bcl-2 expression on fine-needle aspirates from primary breast carcinoma: correlation with other biologic factors. Bozzetti C; Nizzoli R; Naldi N; Guazzi A; Camisa R; Bella MA; Cocconi G Cancer; 1999 Aug; 87(4):224-30. PubMed ID: 10455211 [TBL] [Abstract][Full Text] [Related]
8. ThinPrep vs. conventional smear cytologic preparations in analyzing fine-needle aspiration specimens from palpable breast masses. Biscotti CV; Shorie JH; Gramlich TL; Easley KA Diagn Cytopathol; 1999 Aug; 21(2):137-41. PubMed ID: 10425053 [TBL] [Abstract][Full Text] [Related]
9. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673 [TBL] [Abstract][Full Text] [Related]
10. Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsy. Khoury T; Zakharia Y; Tan W; Kulkarni S; Liu W; Zhang S; Wilding GE; Edge S Breast J; 2011; 17(2):180-6. PubMed ID: 21306471 [TBL] [Abstract][Full Text] [Related]
11. Assessment of thin-layer breast aspirates for immunocytochemical evaluation of HER2 status. Bédard YC; Pollett AF; Leung SW; O'Malley FP Acta Cytol; 2003; 47(6):979-84. PubMed ID: 14674066 [TBL] [Abstract][Full Text] [Related]
12. Fluorescent cytochemical detection of estrogen and progesterone receptors in breast fine-needle aspirates. Masood S Am J Clin Pathol; 1991 Jan; 95(1):35-40. PubMed ID: 1987750 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of ER, PR, MIB-1, pS2, and nuclear grade in FNA specimens of cT1 breast carcinomas: clinicopathological correlation. Angelidou E; Politi E; Sotiropoulou G; Poulianou E; Koutselini H Diagn Cytopathol; 2006 Aug; 34(8):547-52. PubMed ID: 16850494 [TBL] [Abstract][Full Text] [Related]
14. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides. Tabbara SO; Sidawy MK; Frost AR; Brosky KR; Coles V; Hecht S; Radcliffe G; Sherman ME Cancer; 1998 Dec; 84(6):355-60. PubMed ID: 9915137 [TBL] [Abstract][Full Text] [Related]
15. Assessment of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status in the fine needle aspirates of metastatic breast carcinomas. Monaco SE; Wu Y; Teot LA; Cai G Diagn Cytopathol; 2013 Apr; 41(4):308-15. PubMed ID: 22045649 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of hormone receptors and the histological characteristics of biochemically hormone receptor negative breast cancers. Nishimura R; Saeki T; Ohsumi S; Tani Y; Takashima S Breast Cancer; 2007; 14(1):100-4. PubMed ID: 17245003 [TBL] [Abstract][Full Text] [Related]
17. The role of ThinPrep cytology in the evaluation of estrogen and progesterone receptor content of breast tumors. Konofaos P; Kontzoglou K; Georgoulakis J; Megalopoulou T; Zoumpouli C; Christoni Z; Papadopoulos O; Kouraklis G; Karakitsos P Surg Oncol; 2006 Dec; 15(4):257-66. PubMed ID: 17451941 [TBL] [Abstract][Full Text] [Related]
18. ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies. Ferguson J; Chamberlain P; Cramer HM; Wu HH Diagn Cytopathol; 2013 Jul; 41(7):575-81. PubMed ID: 22807465 [TBL] [Abstract][Full Text] [Related]
19. Comparison of enzyme immunoassay and immunohistochemical measurements of estrogen and progesterone receptors in breast cancer patients. Ferrero-Poüs M; Trassard M; Le Doussal V; Hacène K; Tubiana-Hulin M; Spyratos F Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):267-75. PubMed ID: 11556756 [TBL] [Abstract][Full Text] [Related]